Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alcon Inc | ALC | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 81.09 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 81.09 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 69.44 - 88.2312 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 81.09 | USD |
Alcon Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 40.52B | 499.70M | - | 9.46B | 974M | 1.95 | 41.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alcon News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 82.90 | 83.29 | 80.65 | 81.93 | 833,939 | -1.81 | -2.18% |
| 1 Month | 84.47 | 84.96 | 80.65 | 83.20 | 798,843 | -3.38 | -4.00% |
| 3 Months | 77.24 | 88.2312 | 74.30 | 81.78 | 915,899 | 3.85 | 4.98% |
| 6 Months | 76.04 | 88.2312 | 69.44 | 77.89 | 877,266 | 5.05 | 6.64% |
| 1 Year | 71.13 | 88.2312 | 69.44 | 78.47 | 824,501 | 9.96 | 14.00% |
| 3 Years | 74.00 | 88.78 | 55.21 | 74.18 | 855,827 | 7.09 | 9.58% |
| 5 Years | 55.84 | 88.78 | 39.37 | 67.09 | 989,688 | 25.25 | 45.22% |
Alcon Description
| Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan. |
